Elsayed Mostafa Ali Hassan

Assistant Professor - قائم بعمل رئيس قسم الأورام و الطب النووي

Faculty of medicine

Address: مستشفي سوهاج الجامعي- قسم علاج الأورام و الطب النووي



Clinical Oncology in MD degree in clinical oncology

2018-10-22 20:23:21 |

    Professional Information 1. Overall Aims of Course

 Biological therapy the student should understand the molecular biology of cancer , understand the role of immunotherapy, gene therapy,and monoclonal antibodies in management malignant diseases The student should know the different agents of chemotherapy, hormonal therapy , target therapy and immunotherapy , and different protocols used in management of cancer diseases , able to deal with their toxicities, able to take a decision in the treatment of different types of malignancy. The doctorate student should be able to deal with any recent technology in caner management.

  chemotherapy and bone marrow transplantation The student should know different groups of chemotherapy, indications of use, methods of administration, side effects and complications. The student should know indications of bone marrow transplantation, types of it, how to follow transplant patient.

  paediatric oncology, haemato-oncology and palliative care The student should knows different type of pediatric malignant diseases and their management , understand the malignant hematological diseases and their management including the supportive treatment should be given to the patient due to chemotherapy toxicities , understand bone marrow transplantation and its different types and the drugs used in the procedure and after, and also the student should know different methods of palliative care of cancer patients 26 The student should know to select cancer patients who deserve to be admitted in intensive care unit, know the different measures of intensive care

  radiotherapy and radioisotopes a. The student able to perform techniques of brachytherapy, and know different methods of application and understand the rationale of brachytherapy in different types of malignant diseases b. The student should know isotopes used in tumor imaging and its indication in diagnosis and treating malignant diseases

  Intended Learning Outcomes of Course (ILOs) a) Biological therapy a) Knowledge and understanding: By the end of the course, the student is expected to be able to: a1. Explain different aspects of cancer molecular biology a2. mention immunotherapy agents and its role in cancer treatment a3. Describe gene therapy and its role in cancer treatment a4. Mention monoclonal antibodies and its role in cancer treatment a5. Explain the different rationales of using other agents as the hormonal treatment , target therapy, and immunotherapy in the treatment of malignant disease a6. Mention different chemotherapy protocols and method of administration a7. Mention the different drugs toxicities and interactions a8. List all new technologies in the oncology field b)

Intellectual Skills By the end of the course, the student is expected to be able to: b1. Interpret principles of cancer biology b2. Interpret principles of biotherapy in cancer b3. Evaluate tumor angiogenesis and its role in cancer metastasis and treatment b4. Apply principles of target therapy b5. deal with different side effects of the chemotherapy, hormonal , target therapy, and immunotherapy b6. Understand different rationale of using chemotherapy, hormonal therapy, target therapy, and immunotherapy in treatment malignant disease b7. Use chemotherapy concurrent or sequential with other lines of treatment as surgery, or radiotherapy c) Professional and Practical Skills: By the end of the course, the student is expected to be able to: c1. Integrate immunotherapy in cancer treatment c2. Perform monoclonal antibody protocols c3. Perform some of the novel techniques in oncology field d) General and Transferable Skills: By the end of the course, the student is expected to be able to: d1. Solve cancer problems by using new immunotherapy agents d2. Choose and use appropriate computer programs d3. Write reports about monoclonal antibodies d4. Updating with new agents of chemotherapy, hormonal, target therapy, immunotherapy d5. Updating with new protocols of treatment d6. Understand the principles of using chemotherapy combined with other lines of treatment d7. Present reports in seminars about novel techniques in oncology field

bladder cancer
discuss managment of urinary bladder cancer.... Read more

Nasopharyngeal carcinoma

2018-10-22 21:09:40 Clinical Oncology in MD degree in clinical oncology
Overview Parts of the throat (pharynx) Parts of the throat (pharynx) Nasopharyngeal (nay-zoh-fuh-RIN-jee-ul) carcinoma is cancer that occurs in the nasopharynx, which is Read more

Treatment of Bladder Cancer

2018-10-27 13:52:15 Clinical Oncology in MD degree in clinical oncology
Treatment protocols for bladder cancer are provided below, including those for the following: Chemotherapy Immunotherapy Systemic neoadjuvant and adjuvant therapy. Non-mu Read more

cancer prostate

2018-10-27 14:07:38 Clinical Oncology in MD degree in clinical oncology
Approach Considerations Current guidelines on localized prostate cancer from the American Urological Association (AUA) strongly recommend that selection of a management s Read more